Clinical Trials in Minneapolis

Showing 1561-1580 of 12,418 trials

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

NCT03579875

This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) peripheral blood stem cell (PBSC) transplantation in patients with inherited bone marrow failure (BMF) disorders to eliminate the need for routine graft-versus-host disease (GVHD) immune suppression leading to earlier immune recovery and potentially a reduction in the risk of severe infections after transplantation.

Fanconi AnemiaSevere Aplastic AnemiaMyelodysplastic Syndromes+5 more

Masonic Cancer Center, University of Minnesota48 participantsStarted Nov 2018

Minneapolis, Minnesota, United States

RECRUITINGPhase 4< 1 mile

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

NCT06072482

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Amgen300 participantsStarted Feb 2024

Anchorage, Alaska, United States • Scottsdale, Arizona, United States • Surprise, Arizona, United States +65 more locations

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Find Trials by Condition in Minneapolis

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

A Study of PHN-010 in Patients With Advanced Solid Tumors

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System